Representative before the EPO

Employment test 11 - 50 employees
Company dna cabinet becker and associes
operating since 1999
Headquarter in Paris
active in Legal Services and IP Consulting

Anne-Caroline Starck-Loudes has worked on the following 28 EPO patent applications which have been published in the last five years:

EP11719795

METHOD FOR TREATING SCARS WITH ADAPALENE 0.3%

IPC classification:
A61K 31/192, A61P 17/02
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
EXAMINATION IN PROGRESS
EP12177293

Adapalene for the long-term treatment of acne vulgaris

IPC classification:
A61K 31/192, A61P 17/10
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
EXAMINATION IN PROGRESS
EP11306385

Transient expression lentiviral vectors, preparation and uses thereof

IPC classification:
C12N 15/867
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
APPLICATION WITHDRAWN
EP11815529

DERMATOLOGICAL FOAMS OBTAINED FROM A GEL OR SUSPENSION CONTAINING BENZOYL PEROXIDE

IPC classification:
A61K 9/06, A61K 9/10, A61K 9/12, A61K 31/327, A61P 17/10
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
EXAMINATION REQUESTED
EP11815526

DERMATOLOGICAL FOAMS OBTAINED FROM A GEL OR SUSPENSION CONTAINING A COMBINATION OF ADAPALENE AND BENZOYL PEROXIDE

IPC classification:
A61K 9/06, A61K 9/10, A61K 9/12, A61K 31/192, A61K 31/327
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
EXAMINATION IN PROGRESS
EP11815527

DERMATOLOGICAL FOAMS OBTAINED FROM A GEL OR SUSPENSION CONTAINING ADAPALENE

IPC classification:
A61K 9/06, A61K 9/10, A61K 9/12, A61K 31/192, A61P 17/10
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
EXAMINATION IN PROGRESS
EP12306143

Methods and kits for predicting the sensitivity of a subject to chemotherapy

IPC classification:
C12Q 1/68, G01N 33/574
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Institut Gustave Roussy
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
APPLICATION WITHDRAWN
EP12729152

NEW TH17 DIFFERENTIATION MARKERS FOR ACNE AND USES THEREOF

IPC classification:
C12Q 1/68
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
EXAMINATION IN PROGRESS
EP12729153

NEW TH17 DIFFERENTIATION MARKERS FOR ACNE AND USES THEREOF

IPC classification:
C12Q 1/68
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP12732819

NEW TH-17 DIFFERENTIATION MARKERS FOR ROSACEA AND USES THEREOF

IPC classification:
C12Q 1/68
Applicant:
University of Münster (Westfälische Wilhelms-Universität Münster)
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP12755992

METHODS FOR AGGREGATION AND DIFFERENTIATION OF MAGNETIZED STEM CELLS

IPC classification:
C12N 5/0735, C12N 5/077, C12N 5/0775
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP12761744

A HUMAN EPITHELIAL CELL LINE FOR 3D -MODELIZING OF CANCER AND TREATMENT THEREOF

IPC classification:
C07K 14/025, C12N 5/071, G01N 33/50
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
PATENT GRANTED
EP12761743

HUMAN KERATINOCYTES PTCH1 CELL LINE

IPC classification:
C07K 14/025, C12N 15/867, C12Q 1/68
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
EXAMINATION IN PROGRESS
EP12766635

FIBROBLASTS CELLULAR MODEL FOR ASSESSING EFFICACY OF CANCER TREATMENTS BY SHH/PTCH PATHWAY ANTAGONISTS

IPC classification:
C07K 14/005, C07K 14/025, C07K 14/15, C12N 5/077, C12N 5/10, C12N 15/867
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
EXAMINATION IN PROGRESS
EP13305198

Inhibitors of Na(v) 1.9 channel activity and uses thereof for treating pain

IPC classification:
A61K 31/575, A61P 29/00
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11713731

COMPOUNDS AND USES THEREOF TO INDUCE AN IMMUNOGENIC CANCER CELL DEATH IN A SUBJECT

IPC classification:
C12Q 1/68
Applicant:
Institut Gustave Roussy
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12806026

NANOPARTICLES COMPRISING METALLIC AND HAFNIUM OXIDE MATERIALS, PREPARATION AND USES THEREOF

IPC classification:
A61K 9/51, A61K 33/24, A61P 35/00
Applicant:
Nanobiotix
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP14165240

Compounds and uses thereof to induce an immunogenic cancer cell death in a subject

IPC classification:
A61K 31/7048, C12Q 1/68
Applicant:
Institut Gustave Roussy
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
PATENT GRANTED
EP13306780

AP5B1 as a new marker for moderate to severe acne

IPC classification:
C12Q 1/68
Applicant:
Galderma Research & Development
Applicant:
King's College London
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13306779

OVOL1 as a new marker for moderate to severe acne

IPC classification:
C12Q 1/68
Applicant:
Galderma Research & Development
Applicant:
King's College London
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13306799

Pharmaceutical composition comprising nanoparticles, preparation and uses thereof

IPC classification:
A61K 41/00, A61K 47/48
Applicant:
Nanobiotix
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11704799

GAMETES SEPARATION METHODS, COMPOSITIONS AND USES THEREOF

IPC classification:
C12N 5/00
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
EXAMINATION IN PROGRESS
EP12701014

TRANSGENIC PIG FOR MUTANT GUCY2D AS CONE DYSTROPHY MODEL

IPC classification:
A01K 67/027, C12N 9/88, C12N 15/85
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Applicant:
The University Court of The University of Aberdeen
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14726894

ANTI-REGURGITATION COMPOSITION MAINTAINING GUT MOTILITY

IPC classification:
A61P 1/04, A23L 33/00, A23L 29/231, A23L 29/238
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
EXAMINATION REQUESTED
EP12191293

Use of travoprost for treating hair loss

IPC classification:
A61K 8/37, A61K 31/23, A61K 31/5575, A61P 17/00, A61Q 7/00, A61Q 7/02
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11794796

ANTI-REGURGITATION AND/OR ANTI-GASTROOESOPHAGEAL REFLUX COMPOSITION, PREPARATION AND USES

IPC classification:
A23L 1/0524, A23L 1/054, A23L 1/29, A61P 1/04
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature